PeptidePedia The community reference

Special:RecentChanges

Change log·6,798 revisions·page 60 of 68

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 6,798 changes are logged in total.

6,798Logged changes
575Bot edits
167Page creations
256Active editors

16 October 2024

  1. (diff | hist) m 23:41 Beta cell function 3,162 +416 HalfLifeHavel (talk | contribs) correct the second-messenger pathway named in the lead [rollback]
  2. (diff | hist) 23:12 High-performance liquid chromatography 4,166 +840 ResolutionRoo (talk | contribs) add the system-suitability criteria the method actually specifies [rollback]
  3. (diff | hist) m 21:45 Triple agonist 2,043 ±0 BetaCellBoyd (talk | contribs) split §Pharmacology into receptor binding and downstream signalling [rollback]
  4. (diff | hist) m 15:17 Albumin binding half-life extension 3,157 +336 AmylinAmos (talk | contribs) attribute the gastric-emptying effect to the study that measured it [rollback]
  5. (diff | hist) 11:38 Dual incretin agonist 3,352 +121 ParentCatPansy (talk | contribs) move a stray full stop inside the reference [rollback]
  6. (diff | hist) N 09:00 ChinaPeptides 1,687 +1,687 SVG_Solomon (talk | contribs) create organisation article per PP:VN
  7. (diff | hist) N 09:00 Cold-chain freight 1,900 +1,900 FreightFenna (talk | contribs) start article on the process step
  8. (diff | hist) m 08:17 SUSTAIN trial programme 3,660 +836 API_Aurora (talk | contribs) state the analysis population: intention-to-treat or per-protocol [rollback]
  9. (diff | hist) 08:12 Residual solvent 2,880 +918 TechnicianTeal (talk | contribs) rm the assertion that two laboratories must agree; they need not [rollback]
  10. (diff | hist) 02:25 Dulaglutide 2,958 +1,048 GastroparesisGwen (talk | contribs) give the isoelectric point with the method it was determined by [rollback]
  11. (diff | hist) 00:37 List of GLP-1 receptor agonists 2,257 ±0 Chromatokid (talk | contribs) add the cross-link to the parent article [rollback]
  12. (diff | hist) 00:19 Third-party testing 4,411 +104 Peptide_Pete (talk | contribs) add the cost basis, since it shapes who submits [rollback]

15 October 2024

  1. (diff | hist) 19:52 Insulin syringe 2,790 +141 SubQ_Solveig (talk | contribs) add the diluent volume the example assumes [rollback]
  2. (diff | hist) m 13:35 Bacteriostatic water 2,807 ±0 DeadSpaceDot (talk | contribs) expand §Common misunderstandings [rollback]
  3. (diff | hist) m 11:53 Peptide supply chain 1,378 ±0 Ref_Desk_Ron (talk | contribs) rm a duplicated category [rollback]
  4. (diff | hist) 11:44 Talk:Nantong Guangyuan Chemical 1,244 +77 Ref_Desk_Ron (talk | contribs) /* Multiple trading names: which is the title? */ reply
  5. (diff | hist) 09:52 Talk:Hunan Aslsen Technology 822 +278 BlindSampleBrid (talk | contribs) /* "Verified by" is not a test result */ reply
  6. (diff | hist) 07:34 SELECT trial 2,782 +454 KPV_Kester (talk | contribs) split overlong sentence [rollback]
  7. (diff | hist) N 05:56 USP General Chapter 85 1,276 +1,276 SigFigSindri (talk | contribs) create article — method stub
  8. (diff | hist) 05:45 Placebo-adjusted effect 2,157 +881 DrTitration (talk | contribs) add the PMID [rollback]
  9. (diff | hist) 05:05 HOMA-IR 1,827 +237 PlainNumbersPip (talk | contribs) clarify that the reference interval is not a treatment target [rollback]
  10. (diff | hist) m 05:02 VendorInvestigate 2,824 +231 MissedDoseMik (talk | contribs) rm the ranking language; this wiki publishes no ranking [rollback]
  11. (diff | hist) m b 03:45 Glucose-dependent insulinotropic polypeptide 5,300 +266 CiteBot (talk | contribs) bot: normalise citation format [rollback]
  12. (diff | hist) N 03:23 Aspiration risk under anaesthesia 1,230 +1,230 PreregPriya (talk | contribs) start article; incidence figures to follow

14 October 2024

  1. (diff | hist) 22:37 Adverse effects of GLP-1 receptor agonists 3,137 ±0 MassSpecMarv (talk | contribs) add the monitoring recommendation as attributed to the labelling [rollback]
  2. (diff | hist) 20:17 Glucagon 4,114 +428 SurvodutideSaff (talk | contribs) split overlong sentence [rollback]
  3. (diff | hist) 19:05 Liquid chromatography-mass spectrometry 2,132 ±0 AnalyticalAnnie (talk | contribs) split §Principle from §Practical limitations [rollback]
  4. (diff | hist) 18:31 Weight regain after discontinuation 2,792 +978 AnaesthesiaAoife (talk | contribs) state whether the figure is from a trial or from post-marketing reporting [rollback]
  5. (diff | hist) 18:04 Satiety signalling 3,234 +488 LabRangeLindy (talk | contribs) correct the second-messenger pathway named in the lead [rollback]
  6. (diff | hist) 14:08 Talk:Hunan Aslsen Technology 611 +237 NPOV_Nadia (talk | contribs) /* "Verified by" is not a test result */ reply
  7. (diff | hist) m b 12:44 Vial 11,177 +1,970 StubSorterBot (talk | contribs) bot: update parent category chain [rollback]
  8. (diff | hist) 12:26 Retention time 2,283 +256 HypoHildur (talk | contribs) add category for method validation [rollback]
  9. (diff | hist) 11:31 Talk:Hunan Aslsen Technology 400 +410 VerifyVesna (talk | contribs) /* "Verified by" is not a test result */ new section
  10. (diff | hist) 09:24 Dose escalation schedule 1,918 ±0 A1c_Alder (talk | contribs) rm the individualised advice — the article describes, it does not instruct [rollback]
  11. (diff | hist) m 08:35 TRIUMPH trial programme 1,956 ±0 LeanMassLars (talk | contribs) add the trial acronym expansion at first use [rollback]
  12. (diff | hist) 07:22 Peptide synthesis 3,010 +91 SupplyWatchSuri (talk | contribs) expand §The elementary cycle [rollback]

13 October 2024

  1. (diff | hist) 21:29 Hunan Aslsen Technology 3,306 +696 Compounding_Cate (talk | contribs) convert the product range to a table so the documentation column lines up [rollback]
  2. (diff | hist) 19:37 Glucagon-like peptide-1 7,399 +178 COA_Colwyn (talk | contribs) add the species in which the knockout work was done [rollback]
  3. (diff | hist) 16:04 Solid-phase peptide synthesis 3,349 +631 LedeLeander (talk | contribs) correct the transit-time figure — the source gives a median, not a maximum [rollback]
  4. (diff | hist) m 07:55 Karl Fischer titration 4,811 +330 Chromatokid (talk | contribs) expand §Chemical basis [rollback]
  5. (diff | hist) m b 04:01 GL Biochem (Shanghai) 6,902 ±0 ArchiveBot (talk | contribs) bot: mark outbound storefront link nofollow [rollback]
  6. (diff | hist) 02:34 Gastric emptying 3,153 ±0 LCellLeif (talk | contribs) attribute the gastric-emptying effect to the study that measured it [rollback]

12 October 2024

  1. (diff | hist) m 23:59 Research use only 3,726 +199 DMF_Dermot (talk | contribs) typo [rollback]
  2. (diff | hist) 23:14 Lot traceability 2,794 +126 IncretinIvo (talk | contribs) state the method the reporting service uses, since it is not the only one available [rollback]
  3. (diff | hist) 21:29 Hypoglycaemia 2,490 ±0 ArchiveAudit (talk | contribs) rm the causal wording — spontaneous reports do not establish causation [rollback]
  4. (diff | hist) 19:23 Glossary of peptide terminology 3,438 +1,121 RfC_Rasmus (talk | contribs) correct the sort key so the entry files under its surname [rollback]
  5. (diff | hist) 16:31 Crude peptide 2,285 +415 CrudePeptidePearl (talk | contribs) attribute the stability figure to the study and its duration [rollback]
  6. (diff | hist) m b 11:01 Reverse-phase HPLC 3,045 ±0 StubSorterBot (talk | contribs) bot: flag bare reference [rollback]
  7. (diff | hist) m 07:31 Oral semaglutide 2,537 +408 LiraLotte (talk | contribs) give the INN alongside the trade name at first mention [rollback]
  8. (diff | hist) 05:44 Repackaging 2,063 +230 WeaselWordWim (talk | contribs) fix hyphenation per PP:MOS [rollback]
  9. (diff | hist) m 02:48 Test report forgery 1,322 ±0 IcodecIndra (talk | contribs) fix a dangling clause [rollback]

11 October 2024

  1. (diff | hist) 20:35 Amylin 2,565 +591 SurvodutideSaff (talk | contribs) expand §Amyloid formation [rollback]
  2. (diff | hist) N 19:11 Test report forgery 1,322 +1,322 FreightFenna (talk | contribs) new article: testing and documentation, expansion welcome
  3. (diff | hist) 17:02 Peptide aggregation 2,241 ±0 StateBoardStace (talk | contribs) add the equilibration time to the gradient description [rollback]
  4. (diff | hist) 16:53 Lixisenatide 1,771 +581 HOMA_Hettie (talk | contribs) correct the molar mass — source gives the free-base figure, we had the salt [rollback]
  5. (diff | hist) 15:26 Mass spectrometry 3,840 +812 COA_Colwyn (talk | contribs) add the plate-count expression and define its terms [rollback]
  6. (diff | hist) N 09:00 Dose escalation schedule 1,918 +1,918 EscalationEira (talk | contribs) create article — preparation and handling stub
  7. (diff | hist) 02:59 Certificate of analysis 3,859 +137 DiagramDelphine (talk | contribs) add the difference between a batch certificate and a lot-specific one [rollback]
  8. (diff | hist) m b 02:41 Bacterial endotoxin test 2,929 +505 CiteBot (talk | contribs) bot: normalise citation format [rollback]

10 October 2024

  1. (diff | hist) 17:29 Peptide 3,677 ±0 ReportReaderRilla (talk | contribs) correct the eutectic temperature — source gives a range [rollback]
  2. (diff | hist) 13:17 Lyophilisation 7,435 +2,804 LipidLedgerLou (talk | contribs) rm the blanket claim that excursions are harmless [rollback]
  3. (diff | hist) 11:14 International nonproprietary name 1,106 ±0 CagriCass (talk | contribs) de-duplicate a repeated sentence [rollback]
  4. (diff | hist) 10:28 Talk:Nantong Guangyuan Chemical 1,033 +129 ScopeSeverin (talk | contribs) /* Multiple trading names: which is the title? */ reply
  5. (diff | hist) m 01:55 LEADER trial 2,187 +223 ParentCatPansy (talk | contribs) add the number randomised and the number completing [rollback]
  6. (diff | hist) 01:25 Reconstitution calculator 2,683 +1,020 DrTitration (talk | contribs) add the cross-link from the calculator to the unit-conversion article [rollback]

9 October 2024

  1. (diff | hist) m 21:12 FLOW trial 1,950 +752 LotTraceLuka (talk | contribs) correct the endpoint hierarchy — that was a secondary endpoint [rollback]
  2. (diff | hist) 20:52 WuXi TIDES 4,587 +159 CPeptidePaddy (talk | contribs) rm the adjective — an organisation article describes, it does not praise [rollback]
  3. (diff | hist) m 20:28 Receptor bias 2,105 +167 ProglucagonPia (talk | contribs) give the fasting and postprandial concentrations with the assay named [rollback]
  4. (diff | hist) 10:30 Talk:Area percent purity 1,033 +105 Areapercent_Ayo (talk | contribs) /* The worked example — check the arithmetic */ reply
  5. (diff | hist) 09:52 Talk:Nantong Guangyuan Chemical 822 +201 SourceHunterSile (talk | contribs) /* Multiple trading names: which is the title? */ reply
  6. (diff | hist) N 09:00 International nonproprietary name 1,106 +1,106 PriorAuthPaz (talk | contribs) create article — compound stub
  7. (diff | hist) 06:42 Proglucagon 3,075 ±0 ReceptorRhoda (talk | contribs) rm a duplicated category [rollback]

8 October 2024

  1. (diff | hist) 23:17 Semaglutide 5,578 +567 SecretagogueSol (talk | contribs) state plainly that the research-use-only form is not approved for human use [rollback]
  2. (diff | hist) 22:34 Trifluoroacetate counterion 2,370 +272 LurkerLevi (talk | contribs) add the detection wavelength [rollback]
  3. (diff | hist) m 21:57 Fmoc chemistry 2,683 ±0 GlossaryGleb (talk | contribs) correct the humidity figure — relative humidity needs its temperature [rollback]
  4. (diff | hist) m b 21:43 Area percent purity 2,977 +369 CategoryBot (talk | contribs) bot: normalise unit spacing [rollback]
  5. (diff | hist) 20:17 Intention-to-treat analysis 2,691 +31 TrialsTabitha (talk | contribs) the trial was open-label; the article implied blinding [rollback]
  6. (diff | hist) 16:15 Chain of custody 2,673 +259 BatchNumberBede (talk | contribs) clarify that a QR code on a certificate proves issuance, not content [rollback]
  7. (diff | hist) 16:07 Arcuate nucleus 2,347 ±0 DiagramDelphine (talk | contribs) give the magnitude of the incretin effect as a percentage of the insulin response [rollback]
  8. (diff | hist) m 14:48 Resin cleavage 2,363 ±0 CounterfeitCato (talk | contribs) rm the shipping recommendation — that is advice, not description [rollback]
  9. (diff | hist) 14:37 Talk:Nantong Guangyuan Chemical 611 +249 INN_Ingrid (talk | contribs) /* Multiple trading names: which is the title? */ reply
  10. (diff | hist) 11:19 Talk:Nantong Guangyuan Chemical 400 +210 MoveRequestMio (talk | contribs) /* Multiple trading names: which is the title? */ new section
  11. (diff | hist) 08:52 Talk:Area percent purity 822 +162 LOD_Lorcan (talk | contribs) /* The worked example — check the arithmetic */ reply
  12. (diff | hist) m b 02:23 Reconstitution of lyophilised peptides 3,090 +129 CategoryBot (talk | contribs) bot: add stub category [rollback]
  13. (diff | hist) 01:34 Medutest 2,708 ±0 Peptide_Pete (talk | contribs) state the method the reporting service uses, since it is not the only one available [rollback]
  14. (diff | hist) N 00:25 Lixisenatide 1,190 +1,190 ColdChainCleo (talk | contribs) start article on the compound

7 October 2024

  1. (diff | hist) 17:33 VendorInvestigate 2,593 ±0 BlankVialBo (talk | contribs) state the method the reporting service uses, since it is not the only one available [rollback]
  2. (diff | hist) m b 15:47 Retatrutide 3,482 ±0 ArchiveBot (talk | contribs) bot: expand DOI to full citation [rollback]
  3. (diff | hist) 14:15 Talk:Area percent purity 611 +188 TFA_Counterion (talk | contribs) /* The worked example — check the arithmetic */ reply
  4. (diff | hist) 12:24 Blind sampling 3,109 +142 Chromatokid (talk | contribs) expand §How this wiki handles it [rollback]
  5. (diff | hist) 11:43 Timeline of incretin therapeutics 2,352 ±0 StopperingSteff (talk | contribs) add the excipient list from the labelling [rollback]
  6. (diff | hist) 09:41 Talk:Area percent purity 400 +201 Areapercent_Ayo (talk | contribs) /* The worked example — check the arithmetic */ new section
  7. (diff | hist) N 09:00 Placebo-adjusted effect 1,276 +1,276 DiagramDelphine (talk | contribs) create article — trial programme stub
  8. (diff | hist) 08:17 Injection site rotation 2,900 +745 TitrationTheo (talk | contribs) fix a broken wikilink [rollback]
  9. (diff | hist) 05:51 Batch number 2,494 ±0 BlindSampleBrid (talk | contribs) state the method the reporting service uses, since it is not the only one available [rollback]
  10. (diff | hist) 03:35 Subcutaneous injection 2,958 ±0 DrTitration (talk | contribs) give the worked example to two significant figures throughout [rollback]

6 October 2024

  1. (diff | hist) m 23:48 Bachem Holding (Suzhou) 1,686 ±0 Ref_Desk_Ron (talk | contribs) sentence case in headings per PP:MOS [rollback]
  2. (diff | hist) N 19:43 Peptide aggregation 2,241 +2,241 NewLabNell (talk | contribs) new article: analytical method, expansion welcome
  3. (diff | hist) 18:54 GLP-1 receptor agonist 6,120 +584 EndpointEnid (talk | contribs) correct the molar mass — source gives the free-base figure, we had the salt [rollback]
  4. (diff | hist) m 18:31 Peptide content 2,954 +425 FigureFerdinand (talk | contribs) add the ionisation mode to the mass-spectrometry description [rollback]